EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 154 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $93,872 | +404.5% | 16,763 | +372.1% | 0.00% | – |
| Q1 2024 | $18,607 | -77.5% | 3,551 | -77.6% | 0.00% | – |
| Q4 2023 | $82,880 | -70.4% | 15,847 | -10.9% | 0.00% | -100.0% |
| Q3 2023 | $280,454 | -55.4% | 17,784 | -45.1% | 0.00% | -50.0% |
| Q2 2023 | $629,389 | -22.7% | 32,376 | +12.8% | 0.00% | -50.0% |
| Q1 2023 | $814,474 | -14.1% | 28,709 | -11.5% | 0.00% | -20.0% |
| Q4 2022 | $947,958 | -6.4% | 32,431 | -15.4% | 0.01% | -16.7% |
| Q3 2022 | $1,013,000 | +186.2% | 38,330 | +435.5% | 0.01% | +100.0% |
| Q1 2022 | $354,000 | -29.1% | 7,158 | -26.9% | 0.00% | -25.0% |
| Q4 2021 | $499,000 | +77.6% | 9,793 | +45.5% | 0.00% | 0.0% |
| Q1 2021 | $281,000 | +9.3% | 6,729 | +21.9% | 0.00% | 0.0% |
| Q4 2020 | $257,000 | – | 5,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
| Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
| GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
| SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
| BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
| Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
| Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
| Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
| Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
| SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |